Simard John

Avg. Two Year Performance

No purchase track record
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return----------
Purchase Success Rate----------
Average Sale Return(< 1%)0%0%0%0%
Sale Success Rate0 of 20 of 20 of 20 of 20 of 2
Drugs » Biotechnology

Chief Executive Officer, Director, 10% Owner:

Holdings: 3.82M shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--